4.1 Article

Bromodomain-peptide displacement assays for interactome mapping and inhibitor discovery

期刊

MOLECULAR BIOSYSTEMS
卷 7, 期 10, 页码 2899-2908

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/c1mb05099k

关键词

-

资金

  1. Canadian Institutes for Health Research [1097737]
  2. Canadian Foundation for Innovation
  3. Genome Canada through the Ontario Genomics Institute
  4. GlaxoSmithKline
  5. Karolinska Institutet
  6. Knut and Alice Wallenberg Foundation
  7. Ontario Innovation Trust
  8. Ontario Ministry for Research and Innovation
  9. Merck Co Inc.
  10. Novartis Research Foundation
  11. Swedish Agency for Innovation Systems
  12. Swedish Foundation for Strategic Research
  13. Wellcome Trust [086482/Z/08/Z]
  14. UK Biotechnology and Biological Sciences Research Council (BBSRC)
  15. Biotechnology and Biological Sciences Research Council [BB/G023123/1] Funding Source: researchfish
  16. BBSRC [BB/G023123/1] Funding Source: UKRI

向作者/读者索取更多资源

Histone lysine acetylation is a key component of epigenetic regulation of gene transcription. Bromodomains, found in histone acetyl transferases and other chromatin-associated proteins, bind selectively to acetylated lysines, acting as readers of the histone code, and have recently been shown to contain a druggable binding pocket. Here we report the development of high-throughput assays that quantify the binding of bromodomains to acetylated histone peptides. We have used these assays to screen for histone binding partners of as yet uncharacterized bromodomains, adding to current knowledge of the histone code and expanding the repertoire of assays for chemical probe discovery. We have also demonstrated that these assays can be used to detect small molecule binding from the very weak to the nanomolar range. This assay methodology is thereby anticipated to provide the basis both for broader interactome profiling and for small molecule inhibitor discovery.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.1
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据